Stevanato Group Partners With Aptar Pharma on Pre-Filled Syringe System Testing
Bitget2026/10/27 11:05- Stevanato Group entered a collaboration with Aptar Pharma to support earlier selection of prefilled syringe systems for biologics and other injectable therapies.
- Joint testing combines glass syringes with elastomer components to assess system performance, helping drugmakers identify technical risks earlier in development.
- The work builds on Aptar Pharma’s integrated system-level framework launched in July 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Perfume demand leads growth, Chinese market rebounds: Estée Lauder (EL.US) Q1 revenue and profit exceed expectations, raises full-year guidance
Estée Lauder's revenue and profit both exceeded expectations last quarter, driven by strong performance in the fragrance segment and the Chinese market. The company has raised its full-year guidance.
ECARX (ECX.US) signs memorandum of cooperation with Arm to jointly develop the next-generation high-performance AI computing platform for multiple scenarios
ECARX Holdings (ECX.US), a global provider of full-stack intelligent automotive solutions, announced today the signing of a non-binding memorandum of understanding with Arm.
Crypto prices
More
